Results 121 to 130 of about 10,278 (188)

Nano-functionalized probiotic treats atherosclerosis via inhibiting intestinal microbiota-TMA-TMAO axis

Nature Communications
Many patients are suffering from atherosclerosis without typical risk factors, which can cause severe cardiovascular complications. Trimethylamine N-oxide (TMAO), derived from gut microbes, is a key unconventional contributor to the development of ...
Zhezhe Chen, Qiongjun Zhu, Hong Xu, Yiqing Hu, Yanan Wang, Zhebin Chen, Yao Wang, Xingru Huang, Guosheng Fu, Boxuan Ma, Wenbin Zhang   +10 more
doaj   +1 more source

A systematic review of TMAO, microRNAs, and the oral/gut microbiomes in atherosclerosis and myocardial infarction: mechanistic insights and translational opportunities. [PDF]

J Transl Med
Motte LR, Giarritiello F, Sala L, Drago L.   +3 more
europepmc   +1 more source

Modulating effects of microbiota on synbiotic intervention outcomes for microbiota-derived trimethylamine, trimethylamine N-oxide and indoxyl sulfate in healthy young medical students: insights from a 12-week randomized clinical trial. [PDF]

J Transl Med
Kaczmarczyk M, Kędzierska-Kapuza K, Skonieczna-Żydecka K, Surówka A, Drożdżal S, Lechowicz K, Buszman M, Szkudlarek U, Cembrowska-Lech D, Podsiadło K, Samborowska E, Łoniewski I, Ciechanowski K.   +12 more
europepmc   +1 more source

Associations of trimethylamine N-oxide (TMAO) and its precursors with childhood obesity: a case-control study. [PDF]

BMC Endocr Disord
Li Y, Wang X, Chen M, Xiao M, Ma L, Zhou T, Wang M, Song Q.   +7 more
europepmc   +1 more source

Punicalagin is the key pomegranate polyphenol inhibiting gut microbial trimethylamine (TMA) production from L-carnitine in an <i>in vitro</i> human colon model.

Food Funct
Haarhuis JE, Gamal El-Din MI, Lamprinaki D, Kroon PA.   +3 more
europepmc   +1 more source

Dietary Fatty Acids Modulate Gut Microbiota-Derived Trimethylamine-N-Oxide: Potential Mechanisms and Future Perspective. [PDF]

Nutrients
Kilic E, Basaran P.
europepmc   +1 more source

<b>Gut‒heart axis: emerging therapies targeting trimethylamine</b> <b>N-oxide production</b>. [PDF]

Gut Microbes
Torres ER, Wilcox J, Tang WHW.
europepmc   +1 more source

Diabetic cardiomyopathy from a gut microbiota perspective: research progress and prospects. [PDF]

Front Med (Lausanne)
Liang Y, Gao Y, Wang W, Zhao Z.
europepmc   +1 more source

Elevated serum trimethylamine N-oxide (TMAO) and trimethyllysine in patients with amyotrophic lateral sclerosis (ALS): An exploratory case-control study. [PDF]

IBRO Neurosci Rep
Sotgia S, Zinellu A, Zoroddu S, Pateri MI, Loi E, Pisano A, Sabalic A, Tutedde D, Benedetti AFV, Floris F, Puligheddu M, Valera P, Zavattari P, Borghero G, Madeddu R.   +14 more
europepmc   +1 more source

Integrated Insights into Neurodevelopmental Effects of Trimethylamine N-Oxide (TMAO) and Trimethylamine (TMA): A Multi-Cohort Study Combining Epidemiology and Toxicology

ISEE Conference Abstracts
Léa Maitre, Victoria Catherine De Leeuw, Conny Tm Van Oostrom, Augusto Anguita, Leda Chatzi, Muireann Coen, Regina Gražulevičienė, Barbara Heude, Jesus Ibarluzea, Jordi Julvez, Hector C Keun, Loreto Santa María, Sandra Marquez, Mikel Subiza Perez, Cathrine Thomsen, Mireille B Toledano, Cristina M Villanueva, Martine Vrijheid, John Wright, Lesley Hoyles, Simon Mcarthur, Ellen Victorine Susan Hessel   +21 more
openaire   +1 more source